EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia

Yuyan Wu, Mingying Li, Guangqiang Meng, Yuechan Ma, Jingjing Ye, Tao Sun, Chunyan Ji iD

Cancer Medicine · 2023-09 · 12 (18) · 18588-18596

DOI: 10.1002/cam4.6468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 21.08.2023. Verfasst von Yuyan Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, People's …. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chemotherapy is still the standard regimen for treating acute myeloid leukemia (AML) and its disappointing efficacy requires the urgent need for new therapeutic targets. It is well known that immune response plays an increasingly significant role in the pathogenesis of AML.

Methods

We detected nine single nucleotide polymorphisms (SNPs) in immune checkpoint‐related genes, including PD1, LAG3, TIM3, and TIGIT in 285 AML inpatients and 324 healthy controls. SNP genotyping was performed on the MassARRAY platform. Furthermore, we analyzed the relationship between the susceptibility and prognosis of AML and the selected SNPs.

Results

Our results showed that rs2227982 and rs10204525 in PD1 were significantly associated with susceptibility to AML after false discovery rate correction. PD1 rs10204525 also showed a significant correlation with the response to chemotherapy and risk stratification of AML. Importantly, the AA genotype of PD1 (rs2227982) under the recessive model showed a negative impact on AML prognosis independently.

Conclusions

Our results indicate that PD1 SNPs are important for susceptibility and prognosis in AML, which may provide a new therapeutic target for AML patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteHumansPolymorphism, Single NucleotidePrognosisGenetic Predisposition to DiseaseGenotype

Stichwörter der Autor:innen

PD1acute myeloid leukemiaimmune checkpointprognosissingle nucleotide polymorphismsusceptibility

Autor:innen und Institutionen

  • Department of Hematology, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, People's Republic of China.
  • Shandong Key Laboratory of Immunohematology, Qilu Hospital of Shandong University, Jinan, Shandong Province, People's Republic of China.

ORCID-Profile: Chunyan Ji

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, Y., Li, M., Meng, G., Ma, Y., Ye, J., Sun, T., & Ji, C. (2023). Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia. Cancer Medicine, 12(18), 18588-18596. https://doi.org/10.1002/cam4.6468

Vancouver

Wu Y, Li M, Meng G, Ma Y, Ye J, Sun T, et al. Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia. Cancer Medicine. 2023;12(18):18588-18596. doi:10.1002/cam4.6468

BibTeX
@article{Wu2023,
  author = {Wu, Yuyan and Li, Mingying and Meng, Guangqiang and Ma, Yuechan and Ye, Jingjing and Sun, Tao and Ji, Chunyan},
  title = {Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia},
  journal = {Cancer Medicine},
  year = {2023},
  volume = {12},
  number = {18},
  pages = {18588--18596},
  doi = {10.1002/cam4.6468}
}
Kostenlos starten →